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The innate immune response provides the initial defense against infection. This is accomplished by families of pattern recogni-
tion receptors (PRRs) that bind to conserved molecules in bacteria, fungi and viruses. PRRs are finely regulated by elaborate 
mechanisms to ensure a beneficial outcome in response to foreign invaders. MicroRNAs (miRNAs) are a class of small 
non-coding regulatory RNAs that are emerging as important regulators in immune responses at the post-transcriptional level, 
through the inhibition of translation, or by inducing mRNA degradation. It has been shown that miRNAs have unique expres-
sion profiles in cells of the innate immune systems and play pivotal roles in regulating the signal pathways of innate receptors, 
including Toll-like receptors, RIG-I-like receptors and Nod-like receptors. We have summarized the recent literature providing 
new insights into the regulation of innate receptor pathways by miRNAs. 
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Germline-encoded pattern-recognition receptors (PRRs) are 
microbial sensors of the host innate immune system. They 
recognize components of foreign pathogens, referred to as 
pathogen-associated molecular patterns (PAMPs). Several 
families of PRRs have been characterized, including 
Toll-like receptors (TLRs), RIG-I-like receptors (RLRs) and 
Nod-like receptors (NLRs) [1]. At least 13 different TLRs 
(10 in humans and 13 in mice) have been identified [2]. All 
TLRs have an extracellular sensing leucine-rich repeat 
(LRR) domain, a transmembrane domain, and a highly 
conserved cytoplasmic Toll- and interleukin-1-(IL-1) re-
ceptor (TIR). PAMPs recognized by TLRs include three 
general categories of ligands: proteins; nucleic acids; and 
lipid-based elements derived from a wide range of microbes 
such as bacteria, viruses, parasites and fungi. Two addition-
al families of innate receptors, RLRs and NLRs, have been 
described and join the TLRs as key pathogen sensors [3]. 
The RLR family contains RIG-I, MDA5, and LGP2 as me-
mebers. These RLRs consist of two N-terminal caspase re-
cruitment domains (CARDs), a central DEAD box hel-
icase/ATPase domain, in addition to a C-terminal regulatory 
domain. RLRs recognize the double-stranded (ds) RNA 
generated as the replication intermediate of single-stranded 
(ss) RNA viruses, and the genomic RNA of dsRNA viruses 
[4]. NLRs are a group of intracellular microbial sensors that 
sense microbial products or the products of damaged cells, 
such as ATP and uric acid. NLRs are composed of a central 
nucleotide-binding domain and C-terminal leucine-rich re-
peats [5]. NLRs have been classified into four subfamilies 
with members such as NOD1, NOD2, NACHT, NALPs and 
IPAF. These PRRs have a critical role in both innate and 
adaptive immune responses [6]. 
Following the recognition of PAMPs, PRRs initiate in-
nate immune responses by activating intracellular signaling 
cascades that lead to transcriptional expression of inflam-
matory mediators. These coordinate the elimination of 
pathogens and infected cells [7]. However, any dysregula-
tion of this system leads to inflammatory diseases, autoim-
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mune diseases, or dissemination of pathogens. There is 
growing evidence to indicate that many molecules have 
been identified as positive or negative regulators of signal-
ing for these innate receptors. For TLRs, these include 
membrane molecules (CD11b [8] and PECAM1 [9]), anti-
gen presenting molecules (MHCI [10] and MHCII [11]), 
ubiquitin related proteins (Nrdp1 [12] and CHIP [13]), 
phosphatases (SHP-1 [14], SHP-2 [15], SHIP-1 [16] and 
PTP1B [17]), protein kinases (CaMKII [18]), endo-
some/lysosome-localized molecules (Rab7b [19,20], CLM 
[21]), a co-activator of gene transcription (-catenin [22]), 
HSP70 [23], HSP70L1 [24], and NGF [25]. The regulation 
of RLR and NLR signal pathways has been extensively in-
vestigated recently [26,27]; however, the precise mecha-
nisms of regulation remain to be fully elucidated. 
MicroRNAs (miRNAs) are noncoding RNAs with plei-
otropic effects that are dependent on post-transcriptional 
and translational regulation of gene expression. These 
miRNA-related effects are essential for organ development, 
cell differentiation, and tumor progression [28,29]. MiR-
NAs are short ssRNAs of about 22 nucleotides, which reg-
ulate the expression of target genes at the post-transcrip-        
tional level by binding to their 3′ untranslated regions 
(UTRs). Around 1000 miRNAs have been identified in the 
human genome; more than 30% of protein-coding genes are 
predicted to be regulated by miRNAs at the post-transcrip-       
tional and translational level as each miRNA can potentially 
target thousands of different mRNAs. The biogenesis of 
miRNAs involves two processing steps by two RNaseIII 
enzymes, Drosha and Dicer. This then results in repression 
by translational inhibition, mRNA cleavage, and mRNA 
decay initiated by miRNA-guided deadenylation [30]. An 
accumulation of evidence has shown that miRNAs are in-
volved in PRR signaling of the innate immune system. In 
this review, we aim to provide an overview of the regulation 
of innate receptor pathways by miRNAs, and how miRNAs 
can be used in the development of therapeutics against im-
mune diseases. 
1  Regulation of TLR pathways by miRNAs 
Following ligand binding, TLRs initiate innate immune re-
sponses by activating downstream intracellular signaling 
pathways via the adaptor MyD88 or the adaptor TRIF. This 
induces the production of proinflammatory cytokines and 
type I interferon [31]. Many signal molecules, such as 
adaptor proteins and kinases, transcriptional factors, regu-
latory molecules, and inflammatory cytokines in the TLR 
signal pathway are identified to be likely targets of miRNAs, 
especially the TLR-induced miRNAs [32]. 
TLRs mainly signal through the MyD88-dependent 
pathway, which is responsible for the production of proin-
flammatory cytokines, and the TRIF-dependent pathway, 
leading to the anti-viral effects of TLRs. Previous reports 
have shown that tolerance is established and sustained by 
the activities of miR-146a, -155, -145, -346, -223 and -199a, 
which are known to target key adaptors and kinases of the 
TLR signaling pathway. The miR-146 family is composed 
of two members, miR-146a and miR-146b. MiR-146a is one 
of the most prominent miRNAs induced by TLR signals 
through NF-B activation, and then feeds back to suppress 
TLR-triggered NF-B activation [33]. Like miR-146a, 
miR-155 is known to target the TAK1-binding protein 2 
(TAB2), inhibiting the activation of TAK1, and hence 
NF-B and MAPK, thereby acting as an anti-inflammatory 
agent [34]. Significant targets of miR-155 include IKKε, 
FADD and RIP-1 [35]. The MyD88 adaptor-like protein 
(MAL), which functions as a bridging adaptor for TLR2- 
and TLR4-mediated MyD88-dependent signaling and un-
dergoes proteasomal degradation following TLR2 and 
TLR4 stimulation, has emerged as a target of miR-145 [36]. 
Bruton’s tyrosine kinase (BTK) participates in the TLR4, 
TLR7–TLR8 and TLR9 signaling pathways required for 
NF-B activation, and it has recently been shown that 
miR-346 is strongly induced by treatment with lipopoly-
saccharides (LPS). miR-346 has been shown to target Btk 
mRNA in synovial fibroblasts (FLS) of rheumatoid arthritis 
(RA) patients. Whether miR-346 in macrophages targets 
Btk mRNA needs to be further studied [37]. In macrophages, 
a decrease in miR-15a, -16, and -223 expression levels has 
been shown to correlate with an increase in IKK protein 
expression, suggesting that these miRNAs could function as 
modulators of IKK mRNA and protein expression [38]. 
Chen R et al. identified miR-199a as a regulator of IKK 
which is a major factor promoting a functional TLR-MyD88-  
NF-B pathway to constitutively secrete proinflammato-
ry/protumor cytokines [39]. A link between dysregulation of 
miRNAs and human brain disorders has become increas-
ingly evident [40,41]. Recently, extracellular let-7 has been 
shown to activate the RNA-sensing TLR7 and induce neu-
rodegeneration [42]. 
The stimulation of TLRs delivers signals through adaptor 
molecules and kinases. Ultimately, activation of certain 
transcription factors in the nucleus is the key step to trig-
gering target gene transcription. Targeting of transcription 
factors by miRNAs possibly has an impact on TLR-induced 
gene expression [43]. The most important transcription fac-
tor of the TLR signaling pathway, NF-B, is present in the 
cytoplasm, in an inactive form, and is trapped by an inhibi-
tor of NF-B (IB) proteins. Phosphorylation targets IBs 
for ubiquitination and degradation, allowing NF-B to be 
released into the nucleus and to bind to a response element, 
which starts transcription of the target genes. MiR-9, the 
TLR-responsive miRNA in the MyD88- and NF-B-       
dependent pathways, is shown to directly target Nfkb1 
mRNA and then control the NF-B responses by feedback 
[44]. More recently, miR-210 has been shown to be induced 
by LPS and target Nfkb1 mRNA [45]. The signal transduc-
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tion and activator of transcription (STAT)-mediated feed-
back loop amplifies signaling by cytokines, and enhances 
macrophage responses to microbial inducers like TLR lig-
ands [46]. The expression of STAT3 is found to be modu-
lated by both miR-17-5p and miR-20a, suggesting that 
miRNAs could potentially be used for immunotherapy 
against diseases by blocking STAT3 expression [47]. Pe-
roxisome proliferator-activated receptor  (PPAR) belongs 
to the nuclear hormone receptor superfamily of lig-
and-activated transcription factors and originally has been 
characterized to be an important therapeutic target of 
chronic inflammatory diseases. Jennewein et al. recently 
provided evidence that LPS-induced miR-27b contributes to 
destabilization of PPAR1 mRNA, suggesting that de-
creased PPAR expression by miRNAs prolongs inflamma-
tion, thereby attenuating resolution of inflammation [48]. 
Moreover, the transcriptional co-repressor C/EBP is 
shown to be targeted by miR-155, and the transcriptional 
co-activator p300 is targeted by miR-132 [49,50].  
In addition to directly regulating adaptor molecules and 
kinases, as well as transcription factors of the TLR signaling 
pathway, it is increasingly apparent that miRNAs can target 
the regulators of TLR signaling. MiR-21 is expressed in nu-
merous cancers and has been well established as an ‘onco- 
miR’. Furthermore, miR-21 is implicated as a central player 
in the inflammatory response. The tumor suppressor protein 
programmed cell death 4 (PDCD4), an inhibitor of transla-
tion by targeting eukaryotic translation-initiation factor 4F 
(EIF4F), which is required for the initiation of translation at 
the 5′ UTR of mRNA sequences, has been recently identi-
fied to be a key target of miR-21 during TLR4 signaling in 
macrophages [51]. Iliopoulos et al. found that miR-21 tar-
gets the PTEN tumor suppressor gene that functions through 
the Akt pathway, further underlining the significance of 
miR-21 in inflammation and cancer [52]. Notch1 has also 
been identified as a target of miR-146a in studies of the 
miR-146a–mediated repression of IL-12p70 production in 
TLR9-triggered DCs [53]. O’Connell et al. showed that Src 
homology-2 domain-containing inositol 5-phosphatase 1 
(SHIP1) is a direct target of miR-155, and the repression of 
endogenous SHIP1 by miR-155 results in increased activa-
tion of the kinase Akt during the cellular response to LPS 
[54].  
Activation of TLRs leads to the induction of inflamma-
tory cytokines such as TNF, IL-6, IL-12, and IL-10, and 
chemokines such as MCP-1, MIP-1, IP-10 and RANTES 
[55,56], thereby linking the innate and adaptive immune 
systems. Several miRNAs, such as miR-221, miR-125b and 
miR-939 have been found to target the 3′ UTR of TNF- 
mRNA during LPS tolerance [57,58]. Recently, miR-365, 
miR-142-3p and let-7 were found to target Il6 mRNA, and 
reduced endotoxin-induced mortality. Lu et al. identified 
mIL-12p35 as a molecular target of miR-21, which proba-
bly contributes to polarization of T helper (Th) cells, sug-
gesting a key role for miRNAs in allergic lung inflamma-
tion [59]. More recently, miR-466l has been shown to 
up-regulate IL-10 expression in TLR-triggered macrophag-
es [60]. Ma et al. found that miR-29 suppresses immune 
responses to intracellular pathogens by directly targeting 
IFN- [61].  
2  Regulation of RLR pathways by miRNAs 
The RLR sensors recognize the genetic material of RNA 
viruses in the cytoplasm of infected cells and induce in-
flammatory cytokines and type I interferons. Upon recogni-
tion, conformational changes within these sensors exposing 
the CARD domains of RIG-I and MDA5 are induced. They 
then then interact with the CARD-containing adaptor pro-
tein, IPS-1. IPS-1 localizes to the mitochondria and is re-
quired for downstream signaling to activate IKK-related 
kinases, TBK1/IKKi, which then activates IRF3/IRF7 and 
the subsequent transcription of type I interferons via TRAF3. 
Upon recruitment, IPS-1 also activates NF-B through re-
cruitment of TRADD, FADD, caspase-8, and caspase-10 
[4].  
Several miRNAs can be induced by RIG-I signaling, and 
regulate viral replication through modulating the RIG-I 
pathway and the expression of type I interferon. miR-146a 
has been shown to regulate vesicular stomatitis virus (VSV) 
infection-triggered type I IFN production by negatively 
feeding back and targeting TRAF6, IRAK1 and IRAK2 [62]. 
The stimulator of IFN genes (STING) protein is a recently 
discovered adaptor protein that functions downstream of 
RIG-I and upstream of TBK1 and plays an important role in 
IFN- production. Huang et al. found that endogenous 
STING could be regulated post-transcriptionally by miR-24 
in IEC-6 cells [63]. Interferon- (IFN-) is a critical mo-
lecular mediator of pathogen-induced immune responses 
[64]. Recently, miR-466l has been demonstrated to directly 
target IFN- expression through the 3′ UTR, and inhibit 
host antiviral innate immune responses in Sendai virus 
(SeV)- and VSV-infected macrophages and dendritic cells 
[65]. Li et al. recently found that miR-122 facilitates repli-
cation of hepatitis C virus (HCV) RNA and may partly 
counteract the anti-HCV effect of IFN- [66]. MiR-29a has 
recently been identified to be critical for diminishing the 
sensitivity of the thymic epithelium in stimulating infection 
signals, protecting the thymus against inappropriate involu-
tion via miR-29a-mediated suppression of the IFN-α recep-
tor [67]. Furthermore, using an in-depth analysis of 
miRNomes in resting and IFN-α-activated human natural 
killer (NK) cells, two abundant miRNAs (miR-378 and 
miR-30e) have been shown to be suppressed by IFN- ac-
tivation. They then directly target granzyme B and perforin 
[68].  
Some viral miRNAs can regulate viral and/or host cell 
16 Zhang Y, et al.   Sci China Life Sci   January (2013) Vol.56 No.1 
gene expression. MiR-H2-3p, expressed by herpes simplex 
virus 1 (HSV-1), is now known to affect ICP0, a viral im-
mediate-early transcriptional activator thought to play a key 
role in productive HSV-1 replication and reactivation from 
latency [69]. Liang et al. have recently found that 
miR-K12-11, encoded by Kaposi's sarcoma-associated her-
pesvirus (KSHV) is critical for the modulation of IFN sig-
naling and contributes to maintenance of KSHV latency by 
targeting IKKɛ [70].  
3  Regulation of NLR pathways by miRNAs 
Ligation of NOD1 or NOD2 with related ligands activates 
MAPK- and NF-B-signaling cascades, leading to the pro-
duction of proinflammatory cytokines and chemokines. 
Other NLRs are involved in the assembly and activation of 
inflammasomes, which control the activation of caspase-1, 
and subsequent processing of IL-1 and IL-18 [71]. 
Haneklaus et al. identified that a highly conserved miR-223 
targets the site of the NLRP3 3′ UTR and prevents accumu-
lation of NLRP3 protein, and inhibits IL-1 production 
from the inflammasome. Furthermore, Epstein-Barr virus 
(EBV) can also take advantage of miR-BART15 to limit 
inflammation [72]. Bauernfeind et al. also found that 
miR-223 functions to control NLRP3 inflammasome activ-
ity [73]. It is possible there may be other miRNAs involved 
in the regulation of NLR pathways, but this requires further 
investigation. 
4  Conclusion and perspective 
The goal of inflammation is to resolve an injury and return 
the immune system to homeostasis. Many studies have fo-
cused on cellular and molecular networks that regulate in-
flammation, and recent breakthroughs have been made in 
understanding the roles of miRNAs in innate immunity. 
These miRNAs regulate innate receptor signaling pathways 
and ensuing cytokine responses at multiple epigenetic levels. 
Although the study of miRNAs has opened up many new 
areas in the regulation of innate receptor signaling, the 
mechanistic insight into the precise effects of miRNAs on 
TLR-, RLR- and NLR-mediated inflammatory responses 
are still lacking. In particular, how these miRNA networks 
collaborate together to optimize immune responses requires 
further elucidation. Future studies will illuminate the link 
between changes in miRNA levels and the onset of human 
inflammatory diseases. It is hoped this will lead to using 
miRNAs in diagnostics and therapeutics for the treatment of 
inflammatory diseases, autoimmunity, and cancers [74,75]. 
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